Cargando…
Strategic Development of an Immunotoxin for the Treatment of Glioblastoma and Other Tumours Expressing the Calcitonin Receptor
New strategies aimed at treatment of glioblastoma are frequently proposed to overcome poor prognosis. Recently, research has focused on glioma stem cells (GSCs), some quiescent, which drive expansion of glioblastoma and provide the complexity and heterogeneity of the tumour hierarchy. Targeting quie...
Autores principales: | Gupta, Pragya, Hare, David L., Wookey, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466289/ https://www.ncbi.nlm.nih.gov/pubmed/34571996 http://dx.doi.org/10.3390/cells10092347 |
Ejemplares similares
-
Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma
por: Gupta, Pragya, et al.
Publicado: (2020) -
Methods to measure calcitonin receptor activity, up-regulated in cell stress, apoptosis and autophagy
por: Wookey, Peter, et al.
Publicado: (2021) -
Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017) -
Treatment of solid tumors with immunotoxins
por: Messmer, Davorka, et al.
Publicado: (2005) -
A novel ligand of calcitonin receptor reveals a potential new sensor that modulates programmed cell death
por: Furness, SGB, et al.
Publicado: (2016)